These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5867538)

  • 1. Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine.
    Cihák A; Veselý J; Sorm F
    Biochim Biophys Acta; 1965 Nov; 108(3):516-8. PubMed ID: 5867538
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine.
    Veselý J; Cihák A; Sorm F
    Cancer Res; 1968 Oct; 28(10):1995-2000. PubMed ID: 5696931
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical mechanism of drug resistance. VII. Inhibition of orotic acid metabolism by 5-azacytidine in leukemic mice sensitive and resistant to 5-azacytidine.
    Veselý J; Cihák A; Sorm F
    Biochem Pharmacol; 1968 Apr; 17(4):519-24. PubMed ID: 5649551
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF 6-AZAURIDINE AND 6-AZACYTIDINE ON THE INTRACELLULAR SYNTHESIS OF RNA IN FOWL LEUKEMIC AND NORMAL MYELOBLASTS IN VITRO.
    VESELY J
    Acta Biol Med Ger; 1964; 12():60-6. PubMed ID: 14140504
    [No Abstract]   [Full Text] [Related]  

  • 5. Incorporation of arabinosyl cytosine into 2-7S ribonucleic acid and cell death.
    Chu MY
    Biochem Pharmacol; 1971 Aug; 20(8):2057-63. PubMed ID: 5137961
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical mechanisms of drug resistance. IV. Development of resistance to 5-azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice.
    Veselý J; Cihák A; Sorm F
    Int J Cancer; 1967 Nov; 2(6):639-46. PubMed ID: 5582283
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
    Plagemann PG; Behrens M; Abraham D
    Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
    Grant S; Cadman E
    Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S; Rauscher F; Jakubowski A; Cadman E
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical mechanisms of drug resistance. 3. Differences in the metabolism of mouse leukaemic cells sensitive and resistant to 5-azacytidine.
    Sorm F; Veselý J; Cihák A
    Acta Biochim Pol; 1966; 13(4):385-94. PubMed ID: 5962444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of histone H5 on the development of virus-induced leukemia and RNA synthesis in leukemic cells].
    Butenko ZA; Smirnova IA; Chernaia ZhA; Kishinskaia EG; Baryshnikova NE
    Vopr Med Khim; 1982; 28(6):37-40. PubMed ID: 7157721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phenylalanine amonia-lyase and phenylalanine deprivation on murine leukemic lymphoblasts in vitro.
    Stith WJ; Hodgins DS; Abell CW
    Cancer Res; 1973 May; 33(5):966-71. PubMed ID: 4735727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of histone H5 on RNA synthesis in leukemic cells and on the translation process in vitro].
    Smirnova IA; Chernaia ZhA; Kishinskaia EG
    Biokhimiia; 1984 Jan; 49(1):136-41. PubMed ID: 6704447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the RNA electrophoretic spectrum of the cells after Rauscher virus infection. The kinetics of leukemic and normal RNA hybridization with Rauscher virus cDNA].
    Smirnova IA
    Dokl Akad Nauk SSSR; 1981; 256(4):1022-4. PubMed ID: 6164528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nucleic acid content of subcellular structures in normal conditions and during experimental leukemia in rats].
    Bala IuM; Lifshits VM
    Probl Gematol Pereliv Krovi; 1971 Dec; 16(12):41-4. PubMed ID: 5159325
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and effects of 5-(beta-D-ribofuranosyl)isocytosine in P815 cells.
    Chou TC; Burchenal JH; Fox JJ; Watanabe KA; Chu CK; Philips FS
    Cancer Res; 1979 Mar; 39(3):720-8. PubMed ID: 427759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal proteins synthesis and exchange in the absence of 28-S and 18-S ribosomal RNA synthesis in L5178Y cells.
    Auger-Buendia MA; Tavitian A
    Biochim Biophys Acta; 1979 Jun; 563(1):129-42. PubMed ID: 497203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the utilization of asparagine by mouse leukemia cells.
    Ubuka T; Meister A
    J Natl Cancer Inst; 1971 Feb; 46(2):291-8. PubMed ID: 5115904
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical mechanisms of drug resistance. XII. Uridine kinases from mouse leukemic cells sensitive and resistant to 5-azacytidine.
    Veselý J; Dvorák M; Cihák A; Sorm F
    Int J Cancer; 1971 Sep; 8(2):310-9. PubMed ID: 4332369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Messenger RNA and ribosomal RNA synthesis in leukemia cells during cell differentiation].
    Neth R; Wiegers U; Beckmann H; Gaedicke G; Winkler K
    Verh Dtsch Ges Inn Med; 1973; 79():406-8. PubMed ID: 4790244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.